Back to Pharma Services
FAMAR
European CDMO with 75+ years of heritage offering end-to-end contract development and manufacturing of finished dosage forms across sterile and non-sterile formats. Operates seven GMP-compliant sites across Germany, Greece, Italy, and Spain with ~1,850 employees.
Why interesting to a deal team
Newly appointed CEO (Bruce Vielle) with successful platform CDMO track record provides direct entry point for strategic growth initiatives and operational improvement during leadership transition.
Experts connected to this company
Sources
- Structured dataPrimaryfamar-group.com
- Page titleOthercontractpharma.com/company-profile/famar-336952
Strongest evidenceStructured data2 public sourcesHow the grades work